QURE · uniQure NV
United States · RS rating 34 · As of 2026-11-03
| Price | 23.87 USD |
|---|---|
| 1-day change | +3.9% |
| RS rating (overall / 1M / 3M / 12M) | 34 / 71 / 10 / 15 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 31 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -43.5% |
| Sales growth Q/Q | +50.5% |
| Distance from 52-week high | +53.2% |
| Market cap (USD) | $1.1B |